Trademarkia Logo

Canada

C$
ADAPTIVE BIOTECHNOLOGIES
REGISTERED

on 9 Aug 2024

Last Applicant/ Owned by

ADAPTIVE BIOTECHNOLOGIES CORP.

1551 Eastlake Avenue E, Suite 200Seattle, WA 98102

US

Serial Number

2119831 filed on 9th Jul 2021

Registration Number

TMA1249469 registered on 9th Aug 2024

Registration expiry Date

9th Aug 2034

Correspondent Address

PIASETZKI NENNIGER KVAS LLP

SUITE 2308120 ADELAIDE STREET WESTTORONTO

ONTARIO

CA

M5H1T1

ADAPTIVE BIOTECHNOLOGIES

Trademark usage description

providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, an Read More

Classification Information


Class [042]
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of medical biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and medical biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of medical biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of medical biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; research and development in the field of immunopharmaceuticals; research and development services in the field of immunology; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services


Classification kind code

11

Class [044]
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; consulting services in the field of medical diagnostic and prognostic testing; medical testing services relating to the diagnosis and treatment of disease; providing medical diagnostic and prognostic testing services


Classification kind code

11

Mark Details


Serial Number

2119831

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 9th Aug 2024
Registration Pending
Submitted for opposition 42
on 22nd May 2024
Advertised
Submitted for opposition 27
on 23rd Apr 2024
Approval Notice Sent
Submitted for opposition 26
on 23rd Apr 2024
Approved
Submitted for opposition 20
on 30th Jan 2023
Examiner's First Report
Submitted for opposition 22
on 29th Jan 2023
Search Recorded
Submitted for opposition 287
on 6th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 9th Jul 2021
Filed
Submitted for opposition 1
on 9th Jul 2021
Created
Submitted for opposition 31
on 9th Jul 2021
Formalized